Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Naoko Shimoda"'
Autor:
Naoko Shimoda1, Yukinao Sakai1 y-sakai@nms.ac.jp, Takuya Nishino2,3, Sayuri Kawasaki1, Akio Hirama1, Tetsuya Kashiwagi1, Masato Iwabu1
Publikováno v:
Journal of Nippon Medical School. 2024, Vol. 91 Issue 2, p172-179. 8p.
Autor:
Naoko Shimoda1, Mariko Ikeda1, Tomohiro Yan1, Sayuri Kawasaki1, Akio Hirama1, Tetsuya Kashiwagi1, Yukinao Sakai1 y-sakai@nms.ac.jp
Publikováno v:
Journal of Nippon Medical School. 2022, Vol. 89 Issue 3, p287-294. 8p.
Autor:
Akio Hirama, Naoko Shimoda, Sayuri Kawasaki, Yukinao Sakai, Tetsuya Kashiwagi, Tomohiro Yan, Mariko Ikeda
Publikováno v:
Journal of Nippon Medical School. 89:287-294
Background Tolvaptan is the first effective drug treatment for autosomal dominant polycystic kidney disease (ADPKD) patients, but few long-term observations of the effects of tolvaptan have been reported. Methods In this single center, retrospective